Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Gil

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Radiation Oncology (London, England)|January 24, 2015
Pneumomediastinum as a complication of SABR for lung metastasesMaría Esperanza Rodríguez-Ruiz, Estefanía Arévalo, Ignacio Gil-Bazo, et al.
Critical Reviews in Oncology/Hematology|March 11, 2016
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?Rafael Caparica, Gilberto de Castro, Ignacio Gil-Bazo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2005
[Dyspnea, oliguria and lower extremities edema in a patient undergoing mediastinic radiotherapy for a non-resectable thymic carcinoma]Ignacio Gil-Bazo, Pedro Azcárate Agüero, Leire Arbea Moreno, et al.
Molecular Cancer|June 1, 2010
TGFBI expression is associated with a better response to chemotherapy in NSCLCMarta Irigoyen, María J Pajares, Jackeline Agorreta, et al.
Brachytherapy|February 3, 2016
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemesAlicia Olarte, Mauricio Cambeiro, Marta Moreno-Jiménez, et al.
Scientific Reports|July 20, 2017
Pixuna virus modifies host cell cytoskeleton to secure infectionPedro Ignacio Gil, Guillermo Albrieu-Llinás, Estela Cecilia Mlewski, et al.
Hospital Practice (1995)|June 17, 2017
Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancerLaura Calsina Juscafresa, Ignacio Gil Bazo, Lukasz Grochowicz, et al.
Journal of Translational Medicine|August 8, 2015
Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasisEduardo Castañón, Christian Rolfo, David Viñal, et al.
Cirugia Espanola|May 11, 2020
The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markersDiego Flores-Funes, José Aguilar-Jiménez, María Martínez-Gálvez, et al.
Journal of Neuro-Oncology|September 17, 2013
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort studyJuan P Fusco, Eduardo Castañón, Omar E Carranza, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Radiation Oncology (London, England)|January 24, 2015
Pneumomediastinum as a complication of SABR for lung metastasesMaría Esperanza Rodríguez-Ruiz, Estefanía Arévalo, Ignacio Gil-Bazo, et al.
Critical Reviews in Oncology/Hematology|March 11, 2016
BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?Rafael Caparica, Gilberto de Castro, Ignacio Gil-Bazo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2005
[Dyspnea, oliguria and lower extremities edema in a patient undergoing mediastinic radiotherapy for a non-resectable thymic carcinoma]Ignacio Gil-Bazo, Pedro Azcárate Agüero, Leire Arbea Moreno, et al.
Molecular Cancer|June 1, 2010
TGFBI expression is associated with a better response to chemotherapy in NSCLCMarta Irigoyen, María J Pajares, Jackeline Agorreta, et al.
Brachytherapy|February 3, 2016
Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemesAlicia Olarte, Mauricio Cambeiro, Marta Moreno-Jiménez, et al.
Scientific Reports|July 20, 2017
Pixuna virus modifies host cell cytoskeleton to secure infectionPedro Ignacio Gil, Guillermo Albrieu-Llinás, Estela Cecilia Mlewski, et al.
Hospital Practice (1995)|June 17, 2017
Endovascular treatment of malignant superior vena cava syndrome secondary to lung cancerLaura Calsina Juscafresa, Ignacio Gil Bazo, Lukasz Grochowicz, et al.
Journal of Translational Medicine|August 8, 2015
Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasisEduardo Castañón, Christian Rolfo, David Viñal, et al.
Cirugia Espanola|May 11, 2020
The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markersDiego Flores-Funes, José Aguilar-Jiménez, María Martínez-Gálvez, et al.
Journal of Neuro-Oncology|September 17, 2013
Neurological and cytological response as potential early predictors of time-to-progression and overall survival in patients with leptomeningeal carcinomatosis treated with intrathecal liposomal cytarabine: a retrospective cohort studyJuan P Fusco, Eduardo Castañón, Omar E Carranza, et al.
Pageof 15